Ohio State University, The James Comprehensive Cancer — Columbus, Ohio

Ohio State University, The James Comprehensive Cancer is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Ohio State University, The James Comprehensive Cancer has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), Relapsed/Refractory AML.

Sponsors: Auron Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ohio State University, The James Comprehensive Cancer?

Ohio State University, The James Comprehensive Cancer has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ohio State University, The James Comprehensive Cancer conducted?

Ohio State University, The James Comprehensive Cancer has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), Relapsed/Refractory AML.

Is Ohio State University, The James Comprehensive Cancer accredited by Crixeo Health?

Ohio State University, The James Comprehensive Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ohio State University, The James Comprehensive Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.